ProCE Banner Series

Community Multidisciplinary Team Workshops on State-of-the Art Urothelial Carcinoma Management

Register now for this CME/CNE/CPE-certified interactive workshop series on therapeutic advances and multidisciplinary treatment strategies for patients with bladder cancer!

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  ACPE
  | AMA
  | ANCC
Credits Available

1.0

Who Should Attend

This program is intended for physicians, nurses, pharmacists, and other healthcare professionals who treat and manage patients with UC.

All Events

Past Events

August

01

2023

Community Multidisciplinary Team Workshops on State-of-the Art Urothelial Carcinoma Management

8:00 AM - 9:00 AM Eastern Time (ET)

Virtual

Private Event | Virtual Group, Bennington, Vermont

August

14

2023

Community Multidisciplinary Team Workshops on State-of-the Art Urothelial Carcinoma Management

11:30 AM - 12:30 PM Eastern Time (ET)

In-personVirtual

Private Event | Host Group MD, Baltimore, Maryland

August

15

2023

Community Multidisciplinary Team Workshops on State-of-the Art Urothelial Carcinoma Management [Open Registration]

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group MI, Royal Oak, Michigan

October

13

2023

Community Multidisciplinary Team Workshops on State-of-the Art Urothelial Carcinoma Management [Open Registration]

7:00 AM - 8:00 AM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group NC, Hendersonville, North Carolina

November

09

2023

Community Multidisciplinary Team Workshops on State-of-the Art Urothelial Carcinoma Management

7:00 AM - 8:00 AM Pacific Time (PT)

Virtual

Private Event | Virtual Group, Post Falls, Idaho

Topics

  • Adjuvant and Neoadjuvant Approaches to MIBC
  • First-line and Maintenance Therapy for Locally Advanced or Metastatic Disease
  • Second-line and Subsequent Therapies
  • Management of Immune-Related Adverse Events

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners to integrate currently available and emerging therapies for treatment of UC. 

Target Audience
This program is intended for physicians, nurses, pharmacists, and other healthcare professionals who treat and manage patients with UC. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate into practice predictive biomarkers to inform personalized patient care
  • Plan adjuvant therapy for patients with high-risk urothelial carcinoma following radical resection
  • Integrate checkpoint inhibitor therapies into practice to optimize the care of patients with advanced urothelial carcinoma considering the available evidence and patient and disease characteristics
  • Select evidence-based targeted therapy approaches for patients with disease progression during or following platinum-containing chemotherapy and/or immune checkpoint inhibitor therapy
  • Incorporate guideline and expert recommendations to optimally manage adverse events associated with the use of immune checkpoint inhibitors
  • Navigate barriers and racial disparities in care to identify and enroll qualified patients in ongoing clinical trials actively investigating targeted systemic therapies and immune checkpoint inhibitor–based regimens for patients across the disease spectrum

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development Activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-134-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Astellas and Seagen.